咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Laparoendoscopic single site,l... 收藏

Laparoendoscopic single site,laparoscopic or open surgery for adrenal tumors:Selecting the optimal approach

Laparoendoscopic single site, laparoscopic or open surgery for adrenal tumors: Selecting the optimal approach

作     者:Christopher B Riedinger Conrad M Tobert Brian R Lane 

作者机构:Michigan State University College of Human MedicineGrand RapidsMI 49503United States Urology DivisionSpectrum Health Hospital SystemGrand RapidsMI 49503United States 

出 版 物:《World Journal of Clinical Urology》 (世界临床泌尿杂志)

年 卷 期:2014年第3卷第2期

页      面:54-65页

学科分类:10[医学] 

主  题:Adrenal masses Surgical approach Indications Open adrenalectomy Laparoscopic adrenalectomy Laparoendoscopic single-site adrenalectomy 

摘      要:Numerous surgical modalities are available to treat adrenal lesions. Minimally-invasive approaches for adrenalectomy are indicated in most circumstances, and new evidence continues to be accumulated. In this context, current indications for open surgical adrenalectomy(OS-A), minimally-invasive adrenalectomy(MI-A), and laparoendoscopic single-site adrenalectomy(LESS-A) remain unclear. A comprehensive Englishlanguage literature review was performed using MEDLINE/Pub MED to identify articles and guidelines pertinent to the surgical management of adrenal tumors. A comprehensive chart review was performed for three illustrative cases. Clinical recommendations were generated based on relevant literature and the expertise of the investigator group. MI-A offers advantages over OS-A in properly selected patients, who experience fewer complications, lower blood loss, and shorter hospital stays. Robot-assisted laparoscopic and retroperitoneoscopic adrenalectomy may offer advantages over transperitoneal surgery, and LESS-A may be an even less-invasive option that will require further evaluation. MI-A remains the surgical treatment of choice for most adrenal lesions. Tumor size and stage are the primary indications for selecting alternative treatment modalities. OS-A remains the gold standard for large tumors( 10 cm) and suspected or known advanced stage malignancy. LESS-A appears to be an appropriate initial approach for small tumors( 4-5 cm), including pheochromocytoma and isolated adrenal metastases.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分